Regeneron Updates Obesity Drug Study as Investors Await Results
at www.tipranks.com (Thu, 12-Nov 11:30 AM)
Regeneron Buy Rating Maintained on Promising MASH Pipeline and Unchanged $1,175 Price Target
at www.tipranks.com (Wed, 11-Nov 11:15 AM)
Citi Sticks to Its Hold Rating for Regeneron (REGN)
at www.tipranks.com (Wed, 11-Nov 7:26 AM)
Regeneron’s MASH Pipeline Supports Buy Rating; Price Target Unchanged at $1,030
at www.tipranks.com (Wed, 11-Nov 6:16 AM)
Regeneron soars as Q3 2026 non-GAAP EPS jumps 70% and Sanofi collaboration revenue climbs 68%
Market Chameleon (Fri, 30-Oct 10:28 AM)
Regeneron posts 70% non-GAAP EPS growth as Sanofi collaboration revenue jumps 68% in Q3 2026
Market Chameleon (Fri, 30-Oct 8:01 AM)
